Propofol (Propofol Fresenius, Propofol Fresenius ( ), Propofol Mct/lct ( ) Fresenius, Propofol Mct/lct Fresenius)
Propofol
Fresenius Kabi South Africa (Pty) Ltd
Registration
- Applicant
- Fresenius Kabi South Africa (Pty) Ltd
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Propofol 1 % fresenius EACH 1,0 ml EMULSION CONTAINS PROPOFOL 10,0 mg | 1 % | 33007733/2.1/0077 | Registered | S5 | None |
| Propofol 2 % fresenius (20 ML ampoule) EACH 1,0 ml EMULSION CONTAINS PROPOFOL 20,0 mg | 2 % 20 MLAmpoule) | 37055337/2.1/0553 | Cancelled | S5 | None |
| Propofol 2 % fresenius (50 ML vial) EACH 1,0 ml EMUSLION CONTAINS PROPOFOL 20,0 mg | 2 % 50 MLVial) | 37055437/2.1/0554 | Cancelled | S5 | None |
| Propofol 2 % fresenius (100 ML vial) EACH 1,0 ml EMULSION CONTAINS PROPOFOL 20,0 mg | 2 % 100 MLVial) | 37055537/2.1/0555 | Cancelled | S5 | None |
| Propofol mct/lct 1% (20 ml) fresenius EACH 1,0 ml EMULSION CONTAINS PROPOFOL 10,0 mg | 1% 20 ml | 41112141/2.1/1121 | Registered | S5 | None |
| Propofol mct/lct 1% (50 ml) fresenius EACH 1,0 ml EMULSION CONTAINS PROPOFOL 10,0 mg | 1% 50 ml | 41112241/2.1/1122 | Registered | S5 | None |
| Propofol mct/lct 1% (100 ml) fresenius EACH 1,0 ml EMULSION CONTAINS PROPOFOL 10,0 mg | 1% 100 ml | 41112341/2.1/1123 | Registered | S5 | None |
| Propofol mct/lct 2% fresenius | 20 mgEmulsion for injection or infusion | 41112441/2.1/1124Approved 30 January 2025 | Registered | S5 | PIPIL |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Propofol
S5: Propofol
Consolidated Schedules 06 July 2026, line 9662
Pharmacological class: Anaesthetics. (class 2.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
This medication's schedule (S5) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.